Our accounts

FINANCIAL REVIEW

The charity’s finances are overseen by both the trustee board as a whole and a finance sub-committee. 

This has been another positive year for the charity with income increasing from £291,843 to £457,401.  One major reason for this increase is that the charity received a legacy during the year to the value of £140,000.

Without this legacy our income would have been £317,000, which was ahead of the £300,000 target we set last year.   Our income in 2005-6 included £39,000 raised from one challenge event. We did not run such an event in 2006-7 and so in real terms we have seen growth of over 25%.  Year end balances are also more positive than last year with £130,239 being carried forward to our reserves.

With 2 million women affected by endometriosis, our levels of funding, although increasing are low and we are only able to undertake a small amount of the projects we would wish to take forward. The long term strategic objectives of the charity are to some degree held up by the challenges of the size of our small team and the large legacy has presented a number of opportunities. 

One area being considered is investing in fundraising, which will enable us to build up our income at a much faster rate, which in turn will allow us to directly support many more people affected by endometriosis.  During 2007-8 the charity’s trustees will be carefully reviewing how best to make use of this exciting opportunity.

We are very grateful for the support of many funders who have supported us during the year including The Department of Health, The Henry Smith Charity, The John Ellerman Foundation, The D’Oyly Carte Charitable Trust, The Garfield Weston Foundation, GlaxoSmithKline plc, Sovereign Health Care, Wickes Trust and Ipsen Ltd.